Range
30.86 - 32.47
Vol / Avg.
360.2K/821.4K
Div / Yield
-
52 Wk
25.72 - 64.37
Mkt Cap
2.9B
Payout Ratio
-
Open
32.2
P/E
7.86
EPS
-2.1
Shares
92.7M
Outstanding
92.7M
Total Float
60.5M
Benzinga - Oct 18, 2021, 5:03AM
load more
Sector: Health Care.Industry: Biotechnology
Relay Therapeutics Inc is a clinical-stage, precision medicines company transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology. The company is advancing its pipeline of medicines to address targets in precision oncology, including its lead product candidates, RLY-4008 and RLY-1971, as well as its PI3Ka mutant selective program, known as the RLY-PI3K1047 program. Its initiated a Phase 1 clinical trial for RLY-1971 in patients with advanced solid tumors in the first quarter of 2020 and a first-in-human clinical trial of RLY-4008 enriched for patients with advanced solid tumors having oncogenic FGFR2 alterations in the third quarter of 2020.

Earnings

see more
Q3 2021Est.ActualSurprise
EPS
(EXPECTED)2021-11-11
REV
Q2 2021Est.ActualSurprise
EPS-0.450-0.640 -0.1900
REV8.000M844.000K-7.156M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Relay Therapeutics Questions & Anwsers

Q

How do I buy Relay Therapeutics (RLAY) stock?

A

You can purchase shares of Relay Therapeutics (NASDAQ: RLAY) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Relay Therapeutics's (RLAY) competitors?

Q

What is the target price for Relay Therapeutics (RLAY) stock?

A

The latest price target for Relay Therapeutics (NASDAQ: RLAY) was reported by HC Wainwright & Co. on August 17, 2021. The analyst firm set a price target for 54.00 expecting RLAY to rise to within 12 months (a possible 74.53% upside). 6 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Relay Therapeutics (RLAY)?

A

The stock price for Relay Therapeutics (NASDAQ: RLAY) is $30.94 last updated Mon Oct 25 2021 20:00:02 GMT+0000 (Coordinated Universal Time).

Q

Does Relay Therapeutics (RLAY) pay a dividend?

A

There are no upcoming dividends for Relay Therapeutics.

Q

When is Relay Therapeutics (NASDAQ:RLAY) reporting earnings?

A

Relay Therapeutics’s $Q3 earnings are confirmed for after-market on $November 11, 2021.

Q

Is Relay Therapeutics (RLAY) going to split?

A

There is no upcoming split for Relay Therapeutics.

Q

What sector and industry does Relay Therapeutics (RLAY) operate in?

A

Relay Therapeutics is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.